AMN vs NBIX · rev $2.98B vs P/E 45, rev $2.36B
AMN Healthcare Services Inc (AMN) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
AMN Healthcare Services Inc (AMN) is a medical care facilities company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMN revenue for 2024-12-31 was $2.98B. Net income was -$147.0M. Revenue was down 21.3% from 2023-12-31 to 2024-12-31. AMN currently screens at market cap $1.23B.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
AMN currently screens at market cap $1.23B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the AMN and NBIX stock pages for the full models.
Not investment advice.